沉默信息调节因子2相关酶3调控机制及其在疾病中的作用

doi:10.12160/j.issn.1672-5190.2023.01.005

摘要/Abstract

摘要：

沉默信息调节因子2相关酶3（silent information regulator 2-related enzyme 3，SIRT3）是烟酰胺腺嘌呤二核苷酸（nicotinamide adenine dinucleotide，NAD⁺）依赖性组蛋白去乙酰化酶家族成员，参与能量代谢、氧化应激和细胞凋亡等过程并起到关键作用，其调控作用与多种疾病的发生密切相关。综述了SIRT3下游转录因子腺苷酸活化蛋白激酶（AMP-activated protein kinase，AMPK）、线粒体通透性转换孔（mitochondrial permeability transition pore，mPTP）、核因子κB（nuclear factor-κB，NF-κB）等的调控机制，以及SIRT3在心血管疾病、肿瘤、糖尿病中的作用，以期为相关疾病的预防和治疗提供参考。

Abstract:

Silent information regulator 2-related enzyme 3 （SIRT3）, a member of nicotinamide adenine dinucleotide （NAD⁺）-dependent histone deacetylase family, gets involved and plays important roles in energy metabolism, oxidative stress and apoptosis. Its regulatory roles are closely associated with the occurrence of several diseases. This paper reviews the regulatory mechanisms of downstream transcription factors of SIRT3 such as AMP-activated protein kinase （AMPK）, mitochondrial permeability transition pore （mPTP） and nuclear factor-κB （NF-κB）, as well as the roles of SIRT3 in cardiovascular diseases, tumors and diabetes mellitus, in hoping to provide references for the prevention and treatment of related diseases.

Key words: silent information regulator 2-related enzyme 3, Sirtuin, mitochondria, reactive oxygen species, diseases

中图分类号:

沙萍, 冀思同, 曹佩佩, 李梦吉, 马燕芬. 沉默信息调节因子2相关酶3调控机制及其在疾病中的作用[J]. 畜牧与饲料科学, 2023, 44(1): 32-37.

SHA Ping, JI Si-tong, CAO Pei-pei, LI Meng-ji, MA Yan-fen. Regulatory Mechanisms of Silent Information Regulator 2-related Enzyme 3 and Its Roles in Diseases[J]. Animal Husbandry and Feed Science, 2023, 44(1): 32-37.

参考文献 48

[1]	SUN W, LIU C X, CHEN Q H, et al. SIRT3: A new regulator of cardiovascular diseases[J]. Oxidative Medicine and Cellular Longevity, 2018, 2018:7293861.
[2]	SCHWER B, BUNKENBORG J, VERDIN R O, et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(27):10224-10229. doi: 10.1073/pnas.0603968103 pmid: 16788062
[3]	HALLOWS W C, LEE S S, DENU J M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases[J]. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(27):10230-10235. doi: 10.1073/pnas.0604392103 pmid: 16790548
[4]	SHIMAZU T, HIRSCHEY M D, HUA L, et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production[J]. Cell Metabolism, 2010, 12(6):654-661. doi: 10.1016/j.cmet.2010.11.003 pmid: 21109197
[5]	YI W J, XIE X, DU M Y, et al. Green tea polyphenols ameliorate the early renal damage induced by a high-fat diet via ketogenesis/SIRT3 pathway[J]. Oxidative Medicine and Cellular Longevity, 2017, 2017:9032792.
[6]	YANG Y J, CIMEN H, HAN M J, et al. NAD⁺-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10[J]. The Journal of Biological Chemistry, 2010, 285(10):7417-7429. doi: 10.1074/jbc.M109.053421
[7]	BAUSE A S, HAIGIS M C. SIRT3 regulation of mitochondrial oxidative stress[J]. Experimental Gerontology, 2013, 48(7):634-639. doi: 10.1016/j.exger.2012.08.007 pmid: 22964489
[8]	SOMEYA S, YU W, HALLOWS W C, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction[J]. Cell, 2010, 143(5):802-812. doi: 10.1016/j.cell.2010.10.002 pmid: 21094524
[9]	VAN DE VEN R A H, SANTOS D, HAIGIS M C. Mitochondrial sirtuins and molecular mechanisms of aging[J]. Trends in Molecular Medicine, 2017, 23(4):320-331. doi: S1471-4914(17)30024-2 pmid: 28285806
[10]	SIGNORILE A, SANTERAMO A, TAMMA G, et al. Mitochondrial cAMP prevents apoptosis modulating Sirt3 protein level and OPA1 processing in cardiac myoblast cells[J]. Molecular Cell Research, 2017, 1864(2):355-366.
[11]	SAMANT S A, ZHANG H J, HONG Z G, et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress[J]. Molecular and Cellular Biology, 2014, 34(5):807-819. doi: 10.1128/MCB.01483-13 pmid: 24344202
[12]	SUNDARESAN N R, SAMANT S A, PILLAI V B, et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70[J]. Molecular and Cellular Biology, 2008, 28(20):6384-6401. doi: 10.1128/MCB.00426-08 pmid: 18710944
[13]	CHENG A W, YANG Y, ZHOU Y, et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges[J]. Cell Metabolism, 2016, 23(1):128-142. doi: 10.1016/j.cmet.2015.10.013 pmid: 26698917
[14]	BOCHATON T, CROLA-DA-SILVA C, PILLOT B, et al. Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D[J]. Journal of Molecular and Cellular Cardiology, 2015, 84:61-69. doi: 10.1016/j.yjmcc.2015.03.017 pmid: 25871830
[15]	CHAUHAN A S, LIU X G, JING J, et al. STIM2 interacts with AMPK and regulates calcium-induced AMPK activation[J]. FASEB Journal, 2019, 33(2):2957-2970. doi: 10.1096/fj.201801225R pmid: 30335546
[16]	ZHAO W Y, ZHANG L, CHEN R, et al. SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy[J]. Frontiers in Physiology, 2018, 9:1526. doi: 10.3389/fphys.2018.01526 pmid: 30487750
[17]	XIN T, LU C Z. SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury[J]. Aging, 2020, 12(16):16224-16237. doi: 10.18632/aging.v12i16
[18]	YU H L, LIU Q, CHEN G D, et al. SIRT3-AMPK signaling pathway as a protective target in endothelial dysfunction of early sepsis[J]. International Immunopharmacology, 2022, 106:108600. doi: 10.1016/j.intimp.2022.108600
[19]	HAFNER A V, DAI J, GOMES A P, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy[J]. Aging, 2010, 2(12):914-923. doi: 10.18632/aging.v2i12
[20]	YANG Y P, TIAN Y, GUO X S, et al. Ischemia injury induces mPTP opening by reducing Sirt3[J]. Neuroscience, 2021, 468:68-74. doi: 10.1016/j.neuroscience.2021.06.003
[21]	OECKINGHAUS A, GHOSH S. The NF-kappaB family of transcription factors and its regulation[J]. Cold Spring Harbor Perspectives in Biology, 2009, 1(4):a000034.
[22]	SEN R, SMALE S T. Selectivity of the NF- B response[J]. Cold Spring Harbor Perspectives in Biology, 2010, 2(4):a000257.
[23]	LIU L, LU H, LOOR J J, et al. Sirtuin 3 inhibits nuclear factor-κB signaling activated by a fatty acid challenge in bovine mammary epithelial cells[J]. Journal of Dairy Science, 2021, 104(12):12871-12880. doi: 10.3168/jds.2021-20536 pmid: 34482974
[24]	HU D X, LIU X B, SONG W C, et al. Roles of SIRT3 in heart failure: From bench to bedside[J]. Journal of Zhejiang University-SCIENCE B, 2016, 17(11):821-830. doi: 10.1631/jzus.B1600253
[25]	HE W B, HUANG J P, LIU Y, et al. Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression[J]. Cell Death and Disease, 2021, 12:992. doi: 10.1038/s41419-021-04283-6 pmid: 34689162
[26]	ZULLO A, GUIDA R, SCIARRILLO R, et al. Redox homeostasis in cardiovascular disease: The role of mitochondrial sirtuins[J]. Frontiers in Endocrinology, 2022, 13:858330. doi: 10.3389/fendo.2022.858330
[27]	BELL R M, YELLON D M. There is more to life than revascularization: Therapeutic targeting of myocardial ischemia/reperfusion injury[J]. Cardiovascular Therapeutics, 2011, 29(6):e67-e79. doi: 10.1111/cdr.2011.29.issue-6
[28]	PARODI-RULLÁN R M, CHAPA-DUBOCQ X, RULLÁN P J, et al. High sensitivity of SIRT3 deficient hearts to ischemia-reperfusion is associated with mitochondrial abnormalities[J]. Frontiers in Pharmacology, 2017, 8:275. doi: 10.3389/fphar.2017.00275
[29]	HE X C, ZENG H, CHEN J X. Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia[J]. International Journal of Cardiology, 2016, 215:349-357. doi: 10.1016/j.ijcard.2016.04.092 pmid: 27128560
[30]	FREY N, KATUS H A, OLSON E N, et al. Hypertrophy of the heart: A new therapeutic target?[J]. Circulation, 2004, 109(13):1580-1589. doi: 10.1161/01.CIR.0000120390.68287.BB pmid: 15066961
[31]	SUNDARESAN N R, BINDU S, PILLAI V B, et al. SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3β[J]. Molecular and Cellular Biology, 2015, 36(5):678-692. doi: 10.1128/MCB.00586-15 pmid: 26667039
[32]	YANG H Y, YANG T L, BAUR J A, et al. Nutrient-sensitive mitochondrial NAD⁺ levels dictate cell survival[J]. Cell, 2007, 130(6):1095-1107. doi: 10.1016/j.cell.2007.07.035
[33]	YOU J, YUE Z, CHEN S, et al. Receptor-interacting protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes[J]. Acta Physiologica, 2017, 220(1):58-71. doi: 10.1111/apha.2017.220.issue-1
[34]	NIKIFOROV A, DÖLLE C, NIERE M, et al. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: From entry of extracellular precursors to mitochondrial NAD generation[J]. The Journal of Biological Chemistry, 2011, 286(24):21767-21778. doi: 10.1074/jbc.M110.213298
[35]	YUE Z B, MA Y Z, YOU J, et al. NMNAT3 is involved in the protective effect of SIRT3 in Ang Ⅱ-induced cardiac hypertrophy[J]. Experimental Cell Research, 2016, 347(2):261-273. doi: 10.1016/j.yexcr.2016.07.006
[36]	TANG X Q, CHEN X F, CHEN H Z, et al. Mitochondrial sirtuins in cardiometabolic diseases[J]. Clinical Science, 2017, 131(16):2063-2078. doi: 10.1042/CS20160685
[37]	ZHANG S, LIU X B, BAWA-KHALFE T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity[J]. Nature Medicine, 2012, 18(11):1639-1642. doi: 10.1038/nm.2919 pmid: 23104132
[38]	MARQUES-ALEIXO I, SANTOS-ALVES E, MARIANI D, et al. Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress[J]. Mitochondrion, 2015, 20:22-33. doi: 10.1016/j.mito.2014.10.008
[39]	PILLAI V B, BINDU S, SHARP W, et al. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice[J]. American Journal of Physiology Heart and Circulatory Physiology, 2016, 310(8):H962-H972. doi: 10.1152/ajpheart.00832.2015
[40]	DOLINSKY V W. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction[J]. Biological Chemistry, 2017, 398(9):955-974. doi: 10.1515/hsz-2016-0316 pmid: 28253192
[41]	DU Q, ZHU B, ZHAI Q, et al. Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3[J]. American Journal of Translational Research, 2017, 9(7):3360-3373. pmid: 28804553
[42]	DIKALOVA A E, ITANI H A, NAZAREWICZ R R, et al. Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension[J]. Circulation Research, 2017, 121(5):564-574. doi: 10.1161/CIRCRESAHA.117.310933 pmid: 28684630
[43]	HUANG L, YAO T Y, CHEN J, et al. Effect of Sirt3 on retinal pigment epithelial cells in high glucose through Foxo3a/PINK1-Parkin pathway mediated mitophagy[J]. Experimental Eye Research, 2022, 218:109015. doi: 10.1016/j.exer.2022.109015
[44]	OUYANG S M, ZHANG Q Y, LOU L L, et al. The double-edged sword of SIRT3 in cancer and its therapeutic applications[J]. Frontiers in Pharmacology, 2022, 13:871560. doi: 10.3389/fphar.2022.871560
[45]	CALLONI C, MARTÍNEZ L S, GIL D F, et al. Jabuticaba[Plinia trunciflora (O. berg) kausel]protects liver of diabetic rats against mitochondrial dysfunction and oxidative stress through the modulation of SIRT3 expression[J]. Frontiers in Physiology, 2021, 12:665747. doi: 10.3389/fphys.2021.665747
[46]	HUANG X W, SHU H M, REN C Z, et al. SIRT3 improves bone regeneration and rescues diabetic fracture healing by regulating oxidative stress[J]. Biochemical and Biophysical Research Communications, 2022, 604:109-115. doi: 10.1016/j.bbrc.2022.03.001 pmid: 35303676
[47]	LI X Y, YIN Y, LI W F, et al. Omarigliptin alleviates cognitive dysfunction in streptozotocin-induced diabetic mouse[J]. Bioengineered, 2022, 13(4):9387-9396. doi: 10.1080/21655979.2022.2055699 pmid: 35389830
[48]	YANG S J, XU M T, MENG G L, et al. SIRT3 deficiency delays diabetic skin wound healing via oxidative stress and necroptosis enhancement[J]. Journal of Cellular and Molecular Medicine, 2020, 24(8):4415-4427. doi: 10.1111/jcmm.15100 pmid: 32119761